New York: When biotech company Moderna announced last week positive results from a small, preliminary trial of its coronavirus vaccine, the company’s chief medical officer described the news as a “triumphant day for us.” Moderna’s stock price jumped as much as 30 per cent. Its announcement helped lift the stock market and was widely reported […]
Please enter your email to receive our newsletter